TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0230nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0610nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0680nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0780nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0780nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0800nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0890nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0890nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.109nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.206nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.210nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.310nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.326nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.336nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.380nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.438nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.439nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.475nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.537nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.561nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.641nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.727nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.760nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.829nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.884nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.982nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 1.10nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 1.27nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 1.28nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 1.53nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 2.07nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 3.67nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 4.77nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 5.87nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 10.3nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 10.6nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Affinity DataEC50: 25.2nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Affinity DataEC50: 27.1nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Affinity DataEC50: 45nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Affinity DataEC50: 45.4nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Affinity DataEC50: 76.5nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Affinity DataEC50: 84.8nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair